Centro Integral en Reumatologia S.A de C.V /ID# 252872

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Rheumatoid arthritis

Closed trials

• Completed

  Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

  NCT05814627· Phase 3· AbbVie· Source